Skip to main content

7 Result(s)

within J. R. Gonzalez-Porras Remove this filter

and

  1. No Access

    Article

    Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH–SETH

    Venous thromboembolism (VTE) is a serious complication in hematologic neoplasms, so finding adequate prevention strategies is an urgent requirement. However, prospective studies with large enough cohorts are s...

    J. R. Gonzalez-Porras, J. Mateo, V. Gonzalez-Calle… in Clinical and Translational Oncology (2022)

  2. No Access

    Article

    Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation

    D. Rivera, J. M. Bastida, L. Lopez-Corral, F. Sanchez-Guijo… in Bone Marrow Transplantation (2019)

  3. No Access

    Article

    Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines

    Very few data exist on the management of adult patients diagnosed with primary immune thrombocytopenia (ITP). The objectives of this study were to describe the diagnostic and treatment patterns for ITP and to ...

    María Luisa Lozano, N. Revilla, T. J. Gonzalez-Lopez, S. Novelli… in Annals of Hematology (2016)

  4. No Access

    Article

    Slow femoral venous flow and venous thromboembolism following inguinal hernioplasty in patients without or with low molecular weight heparin prophylaxis

    Prosthetic material (mesh) is commonly used to repair inguinal hernias. Its implantation close to the common femoral vein (CFV) can induce slow flow and favor the appearance of venous thromboembolism (VTE) eve...

    F. S. Lozano, J. Sánchez-Fernández, J. R. González-Porras, J. García-Alovio… in Hernia (2015)

  5. No Access

    Article

    Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus

    Transplantation-associated thrombotic microangiopathy (TA-TMA) is a feared complication of allogeneic hematopoietic SCT (HSCT) owing to its high mortality rate. The use of calcineurin inhibitors or sirolimus (...

    J Labrador, L López-Corral, O López-Godino, L Vázquez… in Bone Marrow Transplantation (2014)

  6. No Access

    Article

    Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study

    The aim was to analyze quality-of-life (QOL) during the first year post transplant in 47 patients undergoing reduced-intensity conditioning (RIC) allotransplantation, and to compare these with a similar subgro...

    M Díez-Campelo, J A Pérez-Simón, J R González-Porras… in Bone Marrow Transplantation (2004)

  7. No Access

    Article

    The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma

    We evaluate the efficacy of the oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) in 71 refractory/relapsed multiple myeloma patients, including a prognostic analysis to predict bo...

    R García-Sanz, J R González-Porras, J M Hernández, M Polo-Zarzuela, A Sureda… in Leukemia (2004)